These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 23992124

  • 1. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS, Singh MP, Yadav R.
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [Abstract] [Full Text] [Related]

  • 2. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease.
    Moreira Neto F, Lourenço DM, Noguti MA, Morelli VM, Gil IC, Beltrão AC, Figueiredo MS.
    Braz J Med Biol Res; 2006 Oct; 39(10):1291-5. PubMed ID: 16906320
    [Abstract] [Full Text] [Related]

  • 3. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
    Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY.
    Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376
    [Abstract] [Full Text] [Related]

  • 4. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S.
    Hepatogastroenterology; 2007 Jul; 54(77):1438-42. PubMed ID: 17708272
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O, Fekih-Mrissa N, N'siri B, Ben Hamida A, Benammar-Elgaaied A, Gritli N, Mrissa R.
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
    Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M.
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
    Aydin H, Gunay M, Celik G, Gunay BO, Aydin UT, Karaman A.
    Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
    [Abstract] [Full Text] [Related]

  • 20. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N.
    J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.